Market Overview:
The global anaphylaxis treatment market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of allergic diseases, rising awareness about anaphylaxis and its treatments, and technological advancements in the field of anaphylaxis treatment. The global anaphylaxis treatment market is segmented by type, application, and region. By type, the market is divided into oral treatments, parenteral treatments (injections), and others (such as sublingual therapies). By application, the market is classified into food allergies, pollen allergies, dust mites allergies,, and others (such as drug allergies). The North America region dominates the global anaphylaxis treatment market followed by Europe.
Product Definition:
Anaphylaxis Treatment is the medical care given to a person who is experiencing anaphylaxis, a severe and potentially life-threatening allergic reaction. Anaphylaxis can occur within minutes of exposure to an allergen, such as peanuts or bee venom, or after a longer delay following exposure to a trigger, such as latex. Symptoms of anaphylaxis include swelling of the throat and airways, difficulty breathing, rapid heart rate, dizziness or fainting, and skin rash. If left untreated, anaphylaxis can lead to death. The goal of Anaphylaxis Treatment is to reverse the effects of the allergic reaction and prevent further complications. This may involve administering medication intravenously (through a vein) or by injection into muscle tissue.
Oral:
Oral (inhaled, inhaled/intravenous) is the preferred treatment for anaphylaxis. It allows rapid delivery of epinephrine to the site of action and has a higher rate of success than Intravenous (IV) administration. The drug may be self-administered by patients in emergency situations or it can be administered by healthcare professionals under supervision oral self-administration in hospital settings or home care settings.
Parenteral:
Parenteral is a route of administration used to introduce drugs and fluids into the body. The most common parenteral routes are oral, intravenous, subcutaneous, and intramuscular. Parenteral drug delivery systems help in delivering high concentration of drugs at target site with minimum side effects thereby increasing therapeutic efficacy.
Application Insights:
The food allergy segment dominated the global market in terms of revenue in 2017. This can be attributed to increasing awareness about at-risk groups such as children, elderly people and patients with co-morbidities. According to a study published by the Journal of Allergy and Clinical Immunology, over 50% of patients suffering from severe allergic reactions are under 40 years old. Furthermore, around 20%of these patients have underlying medical conditions such as diabetes mellitus or cardiovascular diseases which increase the risk of allergic reactions significantly.
In addition, growing product availability through various channels including online pharmacies is expected to drive growth during the forecast period for anaphylaxis treatment market owing to ease in accessibility coupled with high patient awareness regarding its benefits among other segments such as pollen allergy.
Regional Analysis:
Europe dominated the global market in terms of revenue in 2017. The presence of well-established healthcare facilities and a large number of allergy clinics in Europe are some factors responsible for its dominance. In addition, increasing awareness about food allergies and their treatment options is also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income, improving healthcare infrastructure, growing patient awareness levels coupled with an increase in product availability & accessibility are few factors driving this regional market at a significant pace. Moreover, increasing prevalence of nutritionally related disorders such as diabetes is further propelling demand for emergency allergic treatments across Asia Pacific region thereby fueling industry expansion over the next eight years (2018 - 2030).
Growth Factors:
- Increasing incidence of anaphylaxis
- Growing awareness about anaphylaxis and its symptoms
- Rising demand for anaphylaxis treatments
- Technological advancements in the field of anaphylaxis treatment
- Availability of government funding for research and development in the field of anaphylaxis treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Anaphylaxis Treatment Market Research Report
By Type
Oral, Parenteral, Others
By Application
Food Allergy, Pollen Allergy, Dust Mites Allergy, Others
By Companies
Pfizer, Mylan, GlaxoSmithKline, Merck, Teva Pharmaceutical, Impax Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Anaphylaxis Treatment Market Report Segments:
The global Anaphylaxis Treatment market is segmented on the basis of:
Types
Oral, Parenteral, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Food Allergy, Pollen Allergy, Dust Mites Allergy, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Mylan
- GlaxoSmithKline
- Merck
- Teva Pharmaceutical
- Impax Laboratories
Highlights of The Anaphylaxis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Parenteral
- Others
- By Application:
- Food Allergy
- Pollen Allergy
- Dust Mites Allergy
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Anaphylaxis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Anaphylaxis treatment is a combination of medications and emergency procedures to help the person with anaphylaxis survive. Treatment may include epinephrine (adrenaline), corticosteroids, and other medications. Emergency procedures may include airway management, CPR, and intravenous fluids.
Some of the major companies in the anaphylaxis treatment market are Pfizer, Mylan, GlaxoSmithKline, Merck, Teva Pharmaceutical, Impax Laboratories.
The anaphylaxis treatment market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Anaphylaxis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Anaphylaxis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Anaphylaxis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Anaphylaxis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Anaphylaxis Treatment Market Size & Forecast, 2018-2028
4.5.1 Anaphylaxis Treatment Market Size and Y-o-Y Growth
4.5.2 Anaphylaxis Treatment Market Absolute $ Opportunity
Chapter 5 Global Anaphylaxis Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Anaphylaxis Treatment Market Size Forecast by Type
5.2.1 Oral
5.2.2 Parenteral
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Anaphylaxis Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Anaphylaxis Treatment Market Size Forecast by Applications
6.2.1 Food Allergy
6.2.2 Pollen Allergy
6.2.3 Dust Mites Allergy
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Anaphylaxis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Anaphylaxis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Anaphylaxis Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Anaphylaxis Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Anaphylaxis Treatment Market Size Forecast by Type
9.6.1 Oral
9.6.2 Parenteral
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Anaphylaxis Treatment Market Size Forecast by Applications
9.10.1 Food Allergy
9.10.2 Pollen Allergy
9.10.3 Dust Mites Allergy
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Anaphylaxis Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Anaphylaxis Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Anaphylaxis Treatment Market Size Forecast by Type
10.6.1 Oral
10.6.2 Parenteral
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Anaphylaxis Treatment Market Size Forecast by Applications
10.10.1 Food Allergy
10.10.2 Pollen Allergy
10.10.3 Dust Mites Allergy
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Anaphylaxis Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Anaphylaxis Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Anaphylaxis Treatment Market Size Forecast by Type
11.6.1 Oral
11.6.2 Parenteral
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Anaphylaxis Treatment Market Size Forecast by Applications
11.10.1 Food Allergy
11.10.2 Pollen Allergy
11.10.3 Dust Mites Allergy
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Anaphylaxis Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Anaphylaxis Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Anaphylaxis Treatment Market Size Forecast by Type
12.6.1 Oral
12.6.2 Parenteral
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Anaphylaxis Treatment Market Size Forecast by Applications
12.10.1 Food Allergy
12.10.2 Pollen Allergy
12.10.3 Dust Mites Allergy
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Anaphylaxis Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Anaphylaxis Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Anaphylaxis Treatment Market Size Forecast by Type
13.6.1 Oral
13.6.2 Parenteral
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Anaphylaxis Treatment Market Size Forecast by Applications
13.10.1 Food Allergy
13.10.2 Pollen Allergy
13.10.3 Dust Mites Allergy
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Anaphylaxis Treatment Market: Competitive Dashboard
14.2 Global Anaphylaxis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Mylan
14.3.3 GlaxoSmithKline
14.3.4 Merck
14.3.5 Teva Pharmaceutical
14.3.6 Impax Laboratories
